MedPath

Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Postoperative Nausea
Postoperative Vomiting
Interventions
Registration Number
NCT03933605
Lead Sponsor
Yeungnam University College of Medicine
Brief Summary

In the present study, midazolam and palonosetron in combination were more effective than palonosetron alone in lowering the incidence and severity of postoperative nausea and vomiting in the initial 2 h after laparoscopic cholecystectomy. Postoperative clinical complications were not different in both groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
88
Inclusion Criteria
  • The patients (aged 20 to 65 years) scheduled for laparoscopic cholecystectomy with American Society of Anesthesiologists (ASA) physical status classification of 1 or 2
Exclusion Criteria
  • The patients with a history of allergy to any other drugs used in this study, gastrointestinal disorder, previous PONV, pregnant woman, breastfeeding woman, use of antiemetics within 24 hours or body mass index > 30 kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
midazolam and palonosetronmidazolam and palonosetron group0.05 mg/kg of midazolam i.v. with 0.075 mg of palonosetron i.v. was administered after anesthetic induction
palonosetronpalonosetron groupthe same volume (0.05 mg/kg) of normal saline i.v. with 0.075 mg of palonosetron i.v. was administered after anesthetic induction
Primary Outcome Measures
NameTimeMethod
incidence of postoperative nausea and vomiting24 hours after surgery

0=none; 1=occur

severity of postoperative nausea and vomiting24 hours after surgery

0 = absent; 1 = mild; 2 = moderate; 3 = severe

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Eun kyung Choi

🇰🇷

Daegu, Korea (the Republic Of), Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath